HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.

AbstractPURPOSE:
Second cancer risk after breast conserving therapy is becoming more important due to improved long term survival rates. In this study, we estimate the risks for developing a solid second cancer after radiotherapy of breast cancer using the concept of organ equivalent dose (OED).
MATERIALS AND METHODS:
Computer-tomography scans of 10 representative breast cancer patients were selected for this study. Three-dimensional conformal radiotherapy (3D-CRT), tangential intensity modulated radiotherapy (t-IMRT), multibeam intensity modulated radiotherapy (m-IMRT), and volumetric modulated arc therapy (VMAT) were planned to deliver a total dose of 50 Gy in 2 Gy fractions. Differential dose volume histograms (dDVHs) were created and the OEDs calculated. Second cancer risks of ipsilateral, contralateral lung and contralateral breast cancer were estimated using linear, linear-exponential and plateau models for second cancer risk.
RESULTS:
Compared to 3D-CRT, cumulative excess absolute risks (EAR) for t-IMRT, m-IMRT and VMAT were increased by 2 ± 15%, 131 ± 85%, 123 ± 66% for the linear-exponential risk model, 9 ± 22%, 82 ± 96%, 71 ± 82% for the linear and 3 ± 14%, 123 ± 78%, 113 ± 61% for the plateau model, respectively.
CONCLUSION:
Second cancer risk after 3D-CRT or t-IMRT is lower than for m-IMRT or VMAT by about 34% for the linear model and 50% for the linear-exponential and plateau models, respectively.
AuthorsYasser Abo-Madyan, Muhammad Hammad Aziz, Moamen M O M Aly, Frank Schneider, Elena Sperk, Sven Clausen, Frank A Giordano, Carsten Herskind, Volker Steil, Frederik Wenz, Gerhard Glatting
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 110 Issue 3 Pg. 471-6 (Mar 2014) ISSN: 1879-0887 [Electronic] Ireland
PMID24444525 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Topics
  • Aged
  • Breast Neoplasms (radiotherapy)
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Radiation-Induced
  • Neoplasms, Second Primary (etiology)
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted (methods)
  • Radiotherapy, Conformal (adverse effects)
  • Radiotherapy, Intensity-Modulated (adverse effects)
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: